首都医科大学学报 ›› 2005, Vol. 26 ›› Issue (4): 474-475.

• 论著·临床研究 • 上一篇    下一篇

辛伐他汀对血脂、载脂蛋白A1、B100及hs-CRP的影响

刘琦, 常志文   

  1. 首都医科大学附属北京同仁医院干部医疗科
  • 收稿日期:2004-11-30 修回日期:1900-01-01 出版日期:2005-08-24 发布日期:2005-08-24

Effects of Simvastatin on apoA1, apoB100 and High Sensitive CRP on Hypercholesterolernia

Liu Qi, Chang Zhiwen   

  1. Department of Geriatrics, Beijing Tongren Hospital, Capital University of Medical Sciences
  • Received:2004-11-30 Revised:1900-01-01 Online:2005-08-24 Published:2005-08-24

摘要:

目的 探讨辛伐他汀调脂治疗对高脂血症患者载脂蛋白A1(apoA1)、apoB100及高敏C反应蛋白(hs-CRP)的影响。方法 选择79例原发性高脂血症患者,辛伐他汀治疗前后检测血脂、apoA1、apoB100及hs-CRP的变化。结果 治疗后血清胆固醇、低密度脂蛋白、apoB100明显降低(P<0.01),apoA1/apoB100比值明显增高(P<0.05),hs-CRP水平明显降低(P<0.01)。结论 辛伐他汀除具有显著调脂作用外,还可减轻炎性反应,多途径抑制动脉粥样硬化的发生和发展.

关键词: 辛伐他汀, 载脂蛋白A1, 载脂蛋白B100, 高敏C反应蛋白

Abstract:

Objective To evaluate the effects of simvastatin on plasma apoprotein A1(apoA1), apoB100 and hs-CRP in hypercholesterolemia.Methods Serum cholesterol, apoA1, apoB100 and hs-CPR were determined before and after treatment with simvastatin 20 mg/d in 79 patients with hypercholesterolemia.Results After treatment with simvastatin, the serum cholesterol, apoB100 as well as hs-CRP were significantly decreased( P <0.01). And the ratio apoA1/apoB100 was increased significantly( P < 0.05 ).Conclusion The lipid lowering treatment with simvastatin can not only decrease serum cholesterol, but also inhibit the inflammation. The results indicate that simvastatin can prevent the development of atherosclerosis by multiple ways.

Key words: simvastatin, apoA1, apoB100, hs-CRP

中图分类号: